Siltuximab administration results in spurious IL-6 elevation in peripheral blood

Am J Hematol. 2024 Jan;99(1):E15-E18. doi: 10.1002/ajh.27132. Epub 2023 Oct 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Castleman Disease*
  • Humans
  • Interleukin-6*

Substances

  • siltuximab
  • Interleukin-6
  • Antibodies, Monoclonal